WaVe生命科学 WVE 深 沪
交易中 09-19 12:41:49 美东时间
5.925
+0.455
+8.32%
华盛通- 最 高5.97
- 今 开5.69
- 成交量 15.67万股
- 最 低 5.66
- 昨 收 5.47
- 总市值 5.86亿
- 52周最高 7.67
- 市盈率 静 --
- 换手率 0.16%
- 52周最低 3.50
- 委 比 -34.65%
- 总股本 9898.33万
- 历史最高 56.00
- 量 比 0.71
- 振 幅 5.67%
- 历史最低 1.16
- 每 手 1
- 风险率 0.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Wave Life Sciences initiated with Overweight at J.P. Morgan
Wave Life Sciences (NASDAQ:WVE) was initiated with an Overweight rating at J.P. Morgan due to potential in market opportunities for WVE-006 and WVE-007. J.P. Morgan set price target for WVE at $10. “W...
09-09 23:07
快讯 | Wave Life Sciences Ltd ：JP Morgan发出超重评级；目标价位为10美元
Wave Life Sciences Ltd : JP Morgan Initiates With Overweight Rating; Price Targ...
09-09 12:30
Dyne stock tumbles 31% amid drug updates, management changes
Shares of Dyne Therapeutics (NASDAQ:DYN) fell 31% Tuesday after the company released new data from a clinical trial called DELIVER for its drug DYNE-251 in the treatment of Duchenne muscular dystrophy...
09-04 04:48
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
William Blair initiates coverage on Korro Bio highlighting its innovative RNA editing platform, ADAR-based OPERA. The analyst rates the stock Outperform, noting its potential in treating alpha-1 antitrypsin deficiency.
08-15 02:21
Wave Life Sciences Shareholders Approve Key Proposals at AGM
Wave Life Sciences (WVE) just unveiled an announcement. Wave Life Sciences Ltd....
08-13 05:52
Wave Life Sciences Gets FDA Rare-Pediatric Designation for WVE-N531
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-12 21:12
快讯 | 美国FDA授予Wave Life Sciences的肌肉疾病治疗方案罕见儿科疾病标签后，Wave Life Sciences股价盘前上涨4.6%
Wave Life Sciences Shares up 4.6% Premarket After US FDA Grants Rare Pediatric ...
08-12 21:07
快讯 | Wave life sciences有限公司的任命凸显了Dmd领域重大未满足需求。
Wave Life Sciences Ltd - Designation Highlights Significant Unmet Needs in Dmd
08-12 20:31
快讯 | Wve-N531潜在的注册前Forward-53试验的二氢鱼蓝蛋白数据将于第三季度发布，Wave Life Sciences处于正轨。
Wave Life Sciences Ltd - Dystrophin Data From Potentially Registrational Forwar...
08-12 20:31
快讯 | Wave Life Sciences公司的Wve-N531因治疗杜兴氏肌营养不良症而获得FDA罕见儿童疾病认定。
Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for Wve-N531...
08-12 20:30
